It has been reported that CAFs may restrain cancer progression as depletion of αSMA+ stromal cells promote an immunosuppressive tumor milieu and exacerbates cancer progression, resulting in diminished survival of PDAC patients [91]. Here, ACTA1 is linked to cancer.